WHIPPANY, N.J., June 17, 2015 /PRNewswire/ -- Bayer HealthCare will present latest data from its investigational compound copanlisib at the 13th International Conference on Malignant Lymphoma (ICML), June 17-20, 2015, in Lugano, Switzerland. Copanlisib is a pan-Class I...